C Partners Holding Gmb H Charles River Laboratories International, Inc. Transaction History

C Partners Holding Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$105.09 - $137.23 $101,201 - $132,152	-963 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $127,469 - $152,971	-1,137 Reduced 54.14%	963 $130,000
Q2 2018 Aug 14, 2018	SELL	$102.37 - $117.25 $1,228 - $1,407	-12 Reduced 0.57%	2,100 $236,000
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $14,237 - $16,704	-145 Reduced 6.42%	2,112 $225,000
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $226,670 - $266,529	2,257	2,257 $247,000

732

51.8M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of C Partners Holding Gmb H, based on Form 13F filings with the SEC.

Stay updated on C Partners Holding Gmb H with notifications on news.